You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Subtype Hgb SC

Showing 1 - 25 of 2,314
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection, Subtype b Trial (Decitabine cycle 1, Romidepsin cycle 1, Decitabine cycle 2)

Recruiting
  • HIV-1-infection, Subtype b
  • Decitabine cycle 1
  • +7 more
  • Bruxelles, Belgium
  • +2 more
Jan 30, 2023

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tislelizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2023

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • Birmingham, Alabama
  • +120 more
Dec 22, 2022

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • efgartigimod PH20 SC
  • +2 more
  • Birmingham, Alabama
  • +130 more
Dec 22, 2022

Angioedema Trial in Worldwide (Lanadelumab, Placebo)

Completed
  • Angioedema
  • Birmingham, Alabama
  • +44 more
Oct 24, 2022

Social Cognition Trial in La Laguna (Cognitive Rehabilitation and Individual Placement and Support)

Completed
  • Social Cognition
  • Cognitive Rehabilitation and Individual Placement and Support
  • La Laguna, Santa CRUZ DE Tenerife, Spain
    Francisco Rodriguez Pulido
May 9, 2023

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

HIV Trial in Austin (VH3810109, rHuPH20)

Recruiting
  • HIV Infections
  • VH3810109
  • rHuPH20
  • Austin, Texas
    GSK Investigational Site
Sep 19, 2022

Juvenile Idiopathic Arthritis Trial in Worldwide (Tocilizumab)

Completed
  • Juvenile Idiopathic Arthritis
  • Little Rock, Arkansas
  • +30 more
Feb 22, 2022

Polycythemia Vera Trial (Hydroxyurea)

Not yet recruiting
  • Polycythemia Vera
  • (no location specified)
May 2, 2023

Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC, efgartigimod IV)

Completed
  • Generalized Myasthenia Gravis
  • efgartigimod PH20 SC
  • efgartigimod IV
  • Carlsbad, California
  • +46 more
Jan 31, 2022

Kidney Injury, Acute Trial in Istanbul (BIOMARKER LEVELS IS IT POSSIBLE TO PREDICT ACUTE RENAL DAMAGE IN THE PREOP PERIOD?)

Recruiting
  • Kidney Injury, Acute
  • BIOMARKER LEVELS IS IT POSSIBLE TO PREDICT ACUTE RENAL DAMAGE IN THE PREOP PERIOD?
  • Istanbul, Turkey
    BakirkoySadiKonuk Training and Searching Hospital
Aug 16, 2022

Melanoma Trial in Worldwide (relatlimab+nivolumab, relatlimab+nivolumab+rHuPH20, nivolumab)

Not yet recruiting
  • Melanoma
  • Anchorage, Alaska
  • +28 more
Oct 20, 2023

HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer Trial in Belgium, France (Pertuzumab and

Recruiting
  • HER2-positive Breast Cancer
  • +3 more
  • Pertuzumab and tratuzumab fixed dose combination
  • Trastuzumab emtansine
  • Auchenflower, Australia
  • +84 more
Jan 16, 2023

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

Recruiting
  • Alzheimer Disease
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Nov 17, 2023

NSCLC Trial in Singapore (Afatinib 40 MG)

Not yet recruiting
  • NSCLC
  • Afatinib 40 MG
  • Singapore, Singapore
    National University Hospital
Sep 25, 2023

CGM in Patients With ED's

Not yet recruiting
  • Anorexia Nervosa Restricting Type
  • +3 more
  • Continuous Glucose Monitor
  • (no location specified)
Oct 28, 2022

Myositis Trial (EFG PH20 SC)

Not yet recruiting
  • Myositis
  • EFG PH20 SC
  • (no location specified)
Jul 28, 2023

Warm Autoimmune Hemolytic Anemia Trial in Riverside (ALXN1830, Placebo)

Withdrawn
  • Warm Autoimmune Hemolytic Anemia
  • Riverside, California
    Clinical Study Site
Feb 2, 2022

Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical

Completed
  • SRP
  • +2 more
  • Measurement of Biomarkers
  • Minneapolis, Minnesota
    University of Minnesota
Sep 21, 2022

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Asthma With Frequent Acute Attacks Phenotype

Not yet recruiting
  • Asthma
  • Observation of clinical indicators related to asthma
  • (no location specified)
Sep 6, 2023